CF Industries Holdings Inc (CF)

Sep 25, 2026

CF Industries Holdings Inc (CF) experienced a 3.2% stock drop, continuing a recent decline, but is still up significantly year-to-date. GuruFocus's GF Value™ suggests the stock is undervalued by 4.9%, trading at $114.67 against an estimated fair value of $120.63, and has a strong GF Score™ of 73/100, particularly in profitability and valuation. However, insider selling of $72.2 million over the past year without purchases and mixed guru activity signal caution for potential investors.

Sep 25, 2026

CVR Partners (NYSE:UAN) is a nitrogen fertilizer producer whose operations are influenced by fertilizer pricing, natural gas costs, and agricultural demand. The company operates facilities in Kansas and Illinois, using both petroleum coke and natural gas as feedstocks. Its financial performance is tied to the cyclical nature of the fertilizer market and agricultural needs across the central United States.

Sep 25, 2026

Mizuho analyst Vijay Rakesh initiated coverage on Tower Semiconductor Ltd (NASDAQ: TSEM) with an Outperform rating and a $300 price target. This article also highlights four other new analyst initiations for Friday, including Precigen (NASDAQ: PGEN) with a Buy rating, Seaport Therapeutics Inc (NASDAQ: SPTX) with a Strong Buy, PDF Solutions Inc (NASDAQ: PDFS) with a Buy, and CF Industries Holdings, Inc. (NYSE: CF) with an Outperform rating. These initiations reflect bullish sentiments from various Wall Street analysts on these respective stocks.

Sep 25, 2026

Argus has lowered its target price for Olin Corporation (OLN) stock to $14.00, with the company currently trading at $16.26. Olin Corp manufactures and sells various chemicals and chemical-based products, organized into three segments. The report also lists several related insider picks and other stock analyses.

Sep 23, 2026

This article provides an exclusive look into various deals across venture capital and private equity. Key highlights include Mirendil's reported talks for a $5 billion valuation, the launch of The Horowitz Andreessen Academy by a16z with $42 million in funding, and Blackstone and EQT's completion of a $6.6 billion buyout of Urbaser. It also covers numerous other funding rounds for startups in AI, medical devices, semiconductor materials, and more.

Sep 22, 2026

CF Industries Holdings (CF) saw its stock pressured after news of a potential U.S.-Belarus potash supply deal, impacting fertilizer pricing. Despite short-term declines, the company has strong longer-term momentum and is considered 26% undervalued based on a fair value of $167.58, supported by its Blue Point low carbon ammonia joint venture. Investors are advised to consider both the upside and downside risks, including project overruns or operational outages, and to conduct further research.

Sep 22, 2026

CF Industries (CF), a large-cap company and the world's largest ammonia producer, has significantly outperformed the agricultural inputs industry and the VanEck Agribusiness ETF (MOO) over the past year. The company's strong performance is attributed to improved financial results in the first half of 2026, including a 92.3% rise in net earnings and an 18.4% increase in net sales, driven by tight global nitrogen supply. While Wall Street analysts currently maintain a "Hold" rating, CF's stock price remains above the mean target, suggesting continued positive sentiment.

Sep 22, 2026

Nutrien (NYSE:NTR; TSX:NTR) shares recovered most of a 5.2% early slide after a proposed U.S.-Belarus potash deal lacked crucial terms like price, volume, and delivery date. The stock initially dropped due to concerns about lower-priced potash imports, but the absence of concrete details allowed for a rebound. Nutrien's sensitivity analysis shows that a $25-per-tonne potash price change impacts its annual adjusted EBITDA by $280 million, underscoring the market's initial reaction to potential price shocks.

Sep 22, 2026

CF Industries Holdings Inc (CF) saw a 3.5% decline, trading at $123.27, which is slightly above its GF Value™ estimate of $120.41, suggesting it is 2.4% overvalued. The company holds an above-average GF Score™ of 73/100, driven by strong profitability but tempered by lower growth and momentum. Notably, insiders have sold $72.2 million worth of shares in the past year, indicating potential caution for investors.

Sep 22, 2026

Shares of Mosaic (MOS) and Nutrien (NTR) experienced a brief decline after President Donald Trump announced that the U.S. is negotiating a deal to purchase potash from Belarus at significantly lower prices than current Canadian supplies. This potential agreement could introduce more low-cost potash into the market, putting pressure on prices and the margins of major producers like Mosaic and Nutrien. While the immediate supply impact from Belarus is expected to be limited due to existing contracts, the long-term implications could include increased competition for Canadian and global suppliers.

Sep 21, 2026

President Donald Trump announced that the U.S. is negotiating a deal with Belarus to acquire potash, a crucial fertilizer component, at reduced prices. Following this announcement, shares of major fertilizer companies CF Industries (CF) and Nutrien (NTR) experienced a decline. The potential deal aims to lower fertilizer costs, impacting the market for existing suppliers.

Sep 18, 2026

CF Industries Holdings (CF) experienced a 3.7% decline in stock value, likely due to profit-taking and concerns over easing nitrogen fertilizer prices from earlier 2026 highs. This downturn is further influenced by recent data showing a general decrease in retail fertilizer pricing and an underweight initiation by a brokerage firm, reinforcing the view that the company may be past its peak nitrogen earnings cycle. The article also details significant hedge fund activity, congressional stock trading, and recent analyst price targets for CF.

Sep 15, 2026

Canaccord cut its price target for The Lovesac Company (NASDAQ: LOVE) from $22 to $20, but maintained a Buy rating, following the company's Q2 fiscal 2027 earnings. While Q2 results were in line with expectations and boosted by tariff refunds, Lovesac lowered its full-year sales and adjusted EBITDA outlook due to product launch delays and the promotional environment. Despite a mixed performance and growth challenges, analysts still see a significant upside of about 43.78% for the stock.